Eradication versus control for poliomyelitis

Affiliations

¹ National Institutes of Health, Bethesda, MD 20892, USA.
² National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: millermark@nih.gov.

Comment

Katherine Sturm-Ramirez et al. Lancet. 2007.

. 2007 Jul 14;370(9582):132-133.

doi: 10.1016/S0140-6736(07)61082-4.

¹ National Institutes of Health, Bethesda, MD 20892, USA.
² National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: millermark@nih.gov.

No abstract available

Comment on

Global poliomyelitis eradication: status and implications.
Fine PE, Griffiths UK. Fine PE, et al. Lancet. 2007 Apr 21;369(9570):1321-1322. doi: 10.1016/S0140-6736(07)60533-9. Lancet. 2007. PMID: 17448799 No abstract available.
Eradication versus control for poliomyelitis: an economic analysis.
Thompson KM, Tebbens RJD. Thompson KM, et al. Lancet. 2007 Apr 21;369(9570):1363-1371. doi: 10.1016/S0140-6736(07)60532-7. Lancet. 2007. PMID: 17448822 Review.